Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.53892 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.46887 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.47061 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.34814 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.38943 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.0826 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.6097 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.69962 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.44265 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.47118 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.46001 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.58796 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.48322 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.47325 | 71 |